BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

935 related articles for article (PubMed ID: 23302240)

  • 21. Choroidal findings in dome-shaped macula in highly myopic eyes: a longitudinal study.
    Viola F; Dell'Arti L; Benatti E; Invernizzi A; Mapelli C; Ferrari F; Ratiglia R; Staurenghi G; Barteselli G
    Am J Ophthalmol; 2015 Jan; 159(1):44-52. PubMed ID: 25244975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY IN CENTRAL SEROUS CHORIORETINOPATHY.
    Chan SY; Wang Q; Wei WB; Jonas JB
    Retina; 2016 Nov; 36(11):2051-2058. PubMed ID: 27164548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CHOROIDAL THICKNESS IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY: Assessment of Haller and Sattler Layers.
    Chung YR; Kim JW; Kim SW; Lee K
    Retina; 2016 Sep; 36(9):1652-7. PubMed ID: 26934451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy.
    Yang L; Jonas JB; Wei W
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4659-65. PubMed ID: 23737472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography.
    Tsujikawa A; Ojima Y; Yamashiro K; Ooto S; Tamura H; Nakagawa S; Yoshimura N
    Retina; 2010 May; 30(5):801-9. PubMed ID: 20094008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy.
    Iida T; Kishi S; Hagimura N; Shimizu K
    Retina; 1999; 19(6):508-12. PubMed ID: 10606450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Choroidal thickness after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy].
    Zeng J; Yan YY; Ding XY; Liu R; Li JQ
    Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):490-4. PubMed ID: 24119960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characteristics of pachydrusen in central serous chorioretinopathy.
    Matsumoto H; Mukai R; Morimoto M; Tokui S; Kishi S; Akiyama H
    Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1127-1132. PubMed ID: 30852634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focal choroidal excavation in patients with central serous chorioretinopathy.
    Luk FO; Fok AC; Lee A; Liu AT; Lai TY;
    Eye (Lond); 2015 Apr; 29(4):453-9. PubMed ID: 25853402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinal Pigment Epithelial Features in Central Serous Chorioretinopathy Identified by Polarization-Sensitive Optical Coherence Tomography.
    Roberts P; Baumann B; Lammer J; Gerendas B; Kroisamer J; Bühl W; Pircher M; Hitzenberger CK; Schmidt-Erfurth U; Sacu S
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1595-603. PubMed ID: 27046123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dilatation of Asymmetric Vortex Vein in Central Serous Chorioretinopathy.
    Hiroe T; Kishi S
    Ophthalmol Retina; 2018 Feb; 2(2):152-161. PubMed ID: 31047342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.
    Ferrara D; Mohler KJ; Waheed N; Adhi M; Liu JJ; Grulkowski I; Kraus MF; Baumal C; Hornegger J; Fujimoto JG; Duker JS
    Ophthalmology; 2014 Mar; 121(3):719-26. PubMed ID: 24289918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations of retinal pigment epithelium in central serous chorioretinopathy.
    Hirami Y; Tsujikawa A; Sasahara M; Gotoh N; Tamura H; Otani A; Mandai M; Yoshimura N
    Clin Exp Ophthalmol; 2007 Apr; 35(3):225-30. PubMed ID: 17430508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INDOCYANINE GREEN ANGIOGRAPHY OF PACHYCHOROID PIGMENT EPITHELIOPATHY.
    Ersoz MG; Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
    Retina; 2018 Sep; 38(9):1668-1674. PubMed ID: 28723851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choroidal vascular alterations evaluated by ultra-widefield indocyanine green angiography in central serous chorioretinopathy.
    Jeong S; Kang W; Noh D; van Hemert J; Sagong M
    Graefes Arch Clin Exp Ophthalmol; 2022 Jun; 260(6):1887-1898. PubMed ID: 35022815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choroidal thickness measurements during central serous chorioretinopathy treatment.
    Brandl C; Helbig H; Gamulescu MA
    Int Ophthalmol; 2014 Feb; 34(1):7-13. PubMed ID: 23572440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biometric characteristics of eyes with central serous chorioretinopathy.
    Oh JH; Oh J; Togloom A; Kim SW; Huh K
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1502-8. PubMed ID: 24550360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of choroidal topographic changes by swept source optical coherence tomography after photodynamic therapy for central serous chorioretinopathy.
    Razavi S; Souied EH; Cavallero E; Weber M; Querques G
    Am J Ophthalmol; 2014 Apr; 157(4):852-60. PubMed ID: 24412124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Choroidal Vascular Changes on Ultrawidefield Indocyanine Green Angiography in Central Serous Chorioretinopathy: CERTAIN Study Report 1.
    Pauleikhoff LJB; Diederen RMH; Chang-Wolf JM; Moll AC; Schlingemann RO; van Dijk EHC; Boon CJF
    Ophthalmol Retina; 2024 Mar; 8(3):254-263. PubMed ID: 37839547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focal choroidal excavation in eyes with central serous chorioretinopathy.
    Ellabban AA; Tsujikawa A; Ooto S; Yamashiro K; Oishi A; Nakata I; Miyake M; Akagi-Kurashige Y; Ueda-Arakawa N; Arichika S; Yoshitake S; Takahashi A; Yoshimura N
    Am J Ophthalmol; 2013 Oct; 156(4):673-83. PubMed ID: 23831223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.